If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email email@example.com .
Please tell us what format you need. It will help us if you say what assistive technology you use.
New recommendations for the use of Synagis®, a passive immunisation to protect infants at risk of serious respiratory syncytial virus (RSV) infection.